Artelo Biosciences (ARTL) Short Interest Ratio & Short Volume $7.20 +0.11 (+1.56%) Closing price 03:58 PM EasternExtended Trading$6.85 -0.34 (-4.74%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Artelo Biosciences Short Interest DataArtelo Biosciences (ARTL) has a short interest of 192,700 shares, representing 5.93% of the float (the number of shares available for trading by the public). This marks a -43.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 23,230 shares to cover all short positions.Current Short Interest192,700 sharesPrevious Short Interest343,500 sharesChange Vs. Previous Month-43.90%Dollar Volume Sold Short$206.19 thousandShort Interest Ratio0.5 Days to CoverLast Record DateMay 31, 2025Outstanding Shares3,281,000 sharesFloat Size3,250,000 sharesShort Percent of Float5.93%Today's Trading Volume38,811 sharesAverage Trading Volume23,230 sharesToday's Volume Vs. Average167% Short Selling Artelo Biosciences? Sign up to receive the latest short interest report for Artelo Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartARTL Short Interest Over TimeARTL Days to Cover Over TimeARTL Percentage of Float Shorted Over Time Artelo Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2025192,700 shares $206.19 thousand -43.9%5.9%0.5 $1.07 5/15/2025343,500 shares $322.89 thousand -11.0%10.6%0.9 $0.94 4/30/2025386,100 shares $378.38 thousand -55.9%11.9%1 $0.98 4/15/2025874,800 shares $901.04 thousand +58,220.0%26.9%2.2 $1.03 3/31/20251,500 shares $1.31 thousand +7.1%0.1%0.1 $0.88 3/15/20251,400 shares $1.34 thousand +16.7%0.0%0.1 $0.96 2/28/20251,200 shares $1.28 thousand -91.0%0.0%0 $1.07 2/15/202513,400 shares $15.95 thousand +55.8%0.4%0.4 $1.19 1/31/20258,600 shares $10.37 thousand -41.1%0.3%0.2 $1.21 1/15/202514,600 shares $16.94 thousand -21.5%0.5%0.5 $1.16 Get the Latest News and Ratings for ARTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/202418,600 shares $19.72 thousand -42.2%0.6%0.6 $1.06 12/15/202432,200 shares $35.74 thousand -2.1%1.0%1.2 $1.11 11/30/202432,900 shares $34.55 thousand +51.6%1.0%1.3 $1.05 11/15/202421,700 shares $22.79 thousand +9.1%0.7%1.3 $1.05 10/31/202419,900 shares $23.68 thousand -26.8%0.6%1.8 $1.19 10/15/202427,200 shares $29.92 thousand -18.3%0.9%3 $1.10 9/30/202433,300 shares $37.30 thousand -8.3%1.0%0.4 $1.12 9/15/202436,300 shares $42.83 thousand -20.7%1.1%0.5 $1.18 8/31/202445,800 shares $59.54 thousand +22.8%1.4%0.6 $1.30 8/15/202437,300 shares $48.49 thousand -20.5%1.2%0.5 $1.30 7/31/202446,900 shares $63.32 thousand +3,808.3%1.5%0.6 $1.35 7/15/20241,200 shares $1.60 thousand -91.5%0.0%0 $1.33 6/30/202414,100 shares $18.89 thousand +2.9%0.4%1.2 $1.34 6/15/202413,700 shares $18.77 thousand +39.8%0.4%1.2 $1.37 5/31/20249,800 shares $13.43 thousand +58.1%0.3%0.7 $1.37 5/15/20246,200 shares $8.18 thousand +26.5%0.2%0.4 $1.32 4/30/20244,900 shares $6.74 thousand -19.7%0.2%0.3 $1.38 4/15/20246,100 shares $9.03 thousand -57.9%0.2%0.4 $1.48 3/31/202414,500 shares $21.46 thousand -28.2%0.5%0.9 $1.48 3/15/202420,200 shares $29.09 thousand +9.2%0.6%1.1 $1.44 2/29/202418,500 shares $28.31 thousand +117.7%0.6%1.1 $1.53 2/15/20248,500 shares $14.71 thousand -38.9%0.3%0.5 $1.73 1/31/202413,900 shares $19.46 thousand -3.5%0.4%0.8 $1.40 1/15/202414,400 shares $21.02 thousand -0.7%0.5%0.7 $1.46 12/31/202314,500 shares $20.30 thousand -44.9%0.5%0.5 $1.40 12/15/202326,300 shares $35.51 thousand -18.1%0.8%0.9 $1.35 11/30/202332,100 shares $45.58 thousand +9.9%1.0%0.9 $1.42 11/15/202329,200 shares $37.67 thousand +3.6%0.9%0.1 $1.29 10/31/202328,200 shares $34.83 thousand -56.4%1.0%0.1 $1.24 10/15/202364,700 shares $92.52 thousand +34.8%2.3%0.2 $1.43Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 9/30/202348,000 shares $70.08 thousand -42.7%1.7%0.2 $1.46 9/15/202383,800 shares $128.21 thousand +357.9%2.9%0.3 $1.53 8/31/202318,300 shares $34.40 thousand +8.9%0.6%0.1 $1.88 8/15/202316,800 shares $33.77 thousand -21.9%0.6%1.3 $2.01 7/31/202321,500 shares $41.07 thousand -16.7%0.8%1.7 $1.91 7/15/202325,800 shares $51.08 thousand -21.8%0.9%1.4 $1.98 6/30/202333,000 shares $66.33 thousand +4.4%1.2%1.8 $2.01 6/15/202331,600 shares $64.46 thousand +10.5%1.1%1.5 $2.04 5/31/202328,600 shares $51.08 thousand +6.7%1.0%1.4 $1.79 5/15/202326,800 shares $45.83 thousand +48.9%1.0%1.3 $1.71 4/30/202318,000 shares $29.34 thousand -77.3%0.6%0.8 $1.63 4/15/202379,300 shares $206.61 thousand +16.3%2.8%4.2 $2.61 3/31/202368,200 shares $158.22 thousand +75.3%2.4%3.3 $2.32 3/15/202338,900 shares $89.47 thousand -30.3%1.4%1.8 $2.30 2/28/202355,800 shares $159.87 thousand -26.0%2.0%2.5 $2.87 2/15/202375,400 shares $226.95 thousand +40.2%2.7%3.3 $3.01 1/31/202353,800 shares $173.24 thousand -34.5%1.9%2.2 $3.22 1/15/202382,100 shares $267.65 thousand -22.9%2.9%3.5 $3.26 12/30/2022106,500 shares $307.79 thousand -16.2%3.7%4.8 $2.89 12/15/2022127,100 shares $374.95 thousand +37.0%4.5%6.2 $2.95 11/30/202292,800 shares $228.29 thousand +4.3%3.3%3.6 $2.46 11/15/202289,000 shares $258.99 thousand +11.1%3.1%2.3 $2.91 10/31/202280,100 shares $229.89 thousand +11.3%2.8%0.2 $2.87 10/15/202272,000 shares $228.24 thousand -4.9%2.5%0.2 $3.17 9/30/202275,700 shares $261.17 thousand +30.1%2.7%0.2 $3.45 9/15/202258,200 shares $240.95 thousand +39.6%2.1%0.2 $4.14 8/31/202241,700 shares $160.55 thousand -33.7%1.5%0.1 $3.85 8/15/202262,900 shares $274.24 thousand -91.5%2.2%0.2 $4.36 7/31/2022737,000 shares $250.65 thousand -17.1%N/A2.2 $0.34 7/15/2022888,500 shares $302.09 thousand -2.4%N/A2.7 $0.34 6/30/2022910,500 shares $288.45 thousand +8.0%N/A0.7 $0.32 6/15/2022843,300 shares $266.65 thousand -15.7%N/A0.6 $0.32 5/31/20221,000,000 shares $331 thousand +80.6%N/A0.7 $0.33 5/15/2022553,600 shares $183.24 thousand -31.3%N/A0.4 $0.33 4/30/2022806,300 shares $308.01 thousand +19.4%N/A0.6 $0.38 4/15/2022675,600 shares $290.51 thousand -30.0%N/A0.5 $0.43 3/31/2022964,800 shares $434.16 thousand +45.6%N/A1.8 $0.45 3/15/2022662,700 shares $265.08 thousand +21.2%N/A1.2 $0.40 2/28/2022546,800 shares $217.24 thousand -19.1%N/A0.9 $0.40 2/15/2022675,700 shares $261.90 thousand +35.4%N/A0.9 $0.39 1/31/2022499,000 shares $209.58 thousand -37.4%N/A0.4 $0.42 1/15/2022797,200 shares $350.77 thousand +4.8%N/A0.1 $0.44 12/31/2021760,700 shares $394.80 thousand -1.8%N/A0.1 $0.52 12/15/2021774,300 shares $446.85 thousand -4.6%N/A0.1 $0.58 11/30/2021811,900 shares $511.50 thousand -36.1%N/A0.1 $0.63 11/15/20211,270,000 shares $1.08 million +69.7%N/A0.2 $0.85 10/29/2021748,300 shares $535.78 thousand -9.8%N/A0.1 $0.72 10/15/2021829,800 shares $634.80 thousand -4.3%N/A2.8 $0.77 9/30/2021866,600 shares $685.05 thousand -27.8%N/A2.9 $0.79 9/15/20211,200,000 shares $990 thousand -2.4%N/A3.5 $0.83Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 8/31/20211,230,000 shares $1.12 million -13.4%N/A3.1 $0.91 8/13/20211,420,000 shares $1.23 million -13.4%N/A3 $0.87 7/30/20211,640,000 shares $1.64 million -6.8%N/A3.4 $1.00 7/15/20211,760,000 shares $1.81 million +4.8%N/A3.7 $1.03 6/30/20211,680,000 shares $2.00 million +0.6%N/A2.7 $1.19 6/15/20211,670,000 shares $1.95 million +3.1%7.6%2.5 $1.17 5/28/20211,620,000 shares $2.01 million -1.8%7.4%1.8 $1.24 5/14/20211,650,000 shares $1.86 million -4.1%N/A1.1 $1.13 4/30/20211,720,000 shares $2.29 million -6.5%N/A0.3 $1.33 4/15/20211,840,000 shares $2.34 million -13.2%N/A0.2 $1.27 3/31/20212,120,000 shares $3.31 million -17.2%N/A0.2 $1.56 3/15/20212,560,000 shares $5.04 million -10.2%N/A0.3 $1.97 2/26/20212,850,000 shares $5.56 million +0.4%N/A0.3 $1.95 2/12/20212,840,000 shares $4.63 million +49.5%N/A0.3 $1.63 1/29/20211,900,000 shares $1.71 million +79.3%N/A0.5 $0.90 1/15/20211,060,000 shares $1.07 million +54.0%N/A0.4 $1.01 12/31/2020688,400 shares $481.12 thousand +16.1%N/A0.3 $0.70 12/15/2020592,900 shares $391.31 thousand +3.1%N/A0.3 $0.66 11/30/2020575,200 shares $345.12 thousand +2.4%N/A0.3 $0.60 11/15/2020562,000 shares $292.30 thousand -39.9%N/A0.3 $0.52 10/30/2020934,400 shares $466.73 thousand +201.7%N/A0.6 $0.50 10/15/2020309,700 shares $240.88 thousand +113.6%N/A0.2 $0.78 9/30/2020145,000 shares $143.93 thousand -9.3%N/A0.2 $0.99 9/15/2020159,900 shares $140.71 thousand +32.0%4.8%0.3 $0.88 8/31/2020121,100 shares $116.26 thousand +76.5%3.6%0.2 $0.96 8/14/202068,600 shares $78.89 thousand +127.9%2.1%0.2 $1.15 7/31/202030,100 shares $34.62 thousand +30.3%1.0%0.1 $1.15 7/15/202023,100 shares $25.41 thousand +266.7%0.8%0.1 $1.10 6/30/20206,300 shares $7.62 thousand +26.0%0.3%0 $1.21 6/15/20205,000 shares $6.30 thousand -70.9%0.2%0 $1.26 ARTL Short Interest - Frequently Asked Questions What is Artelo Biosciences' current short interest? Short interest is the volume of Artelo Biosciences shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 192,700 shares of ARTL short. 5.93% of Artelo Biosciences' shares are currently sold short. Learn More on Artelo Biosciences' current short interest. What is a good short interest percentage for Artelo Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.93% of Artelo Biosciences' floating shares are currently sold short. Is Artelo Biosciences' short interest increasing or decreasing? Artelo Biosciences saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 192,700 shares, a drop of 43.9% from the previous total of 343,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Artelo Biosciences' float size? Artelo Biosciences currently has issued a total of 3,281,000 shares. Some of Artelo Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Artelo Biosciences currently has a public float of 3,250,000 shares. How does Artelo Biosciences' short interest compare to its competitors? 5.93% of Artelo Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Artelo Biosciences: TherapeuticsMD, Inc. (0.74%), Flora Growth Corp. (1.42%), Edesa Biotech, Inc. (0.25%), Equillium, Inc. (0.50%), Citius Pharmaceuticals, Inc. (6.85%), Phio Pharmaceuticals Corp. (4.79%), 23andMe Holding Co. (11.90%), Aytu BioPharma, Inc. (6.96%), Lipella Pharmaceuticals Inc. (3.01%), Athira Pharma, Inc. (2.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Artelo Biosciences stock? Short selling ARTL is an investing strategy that aims to generate trading profit from Artelo Biosciences as its price is falling. ARTL shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Artelo Biosciences? A short squeeze for Artelo Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARTL, which in turn drives the price of the stock up even further. How often is Artelo Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARTL, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies TXMD Short Interest Data FLGC Short Interest Data EDSA Short Interest Data EQ Short Interest Data CTXR Short Interest Data PHIO Short Interest Data ME Short Interest Data AYTU Short Interest Data LIPO Short Interest Data ATHA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARTL) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
